Sitemap - 2024 - The California Stem Cell Report

The End of the Anti-Cancer, 'Don't Eat Me' Effort at Gilead; Blow to California Stem Cell Agency

CIRM's Priorities and Spending: From the Impact of Past Research Investments to Prevalance of Diseases in California

Time to Speak Out: Who Will be the Winners and Losers in CIRM's New Priorities?

Dementia Advocate Urges More Funds for Dementia Research from State Stem Cell Agency

$1.1 Billion at Stake in California for Neuro Disease Research at Hearing Next Week

No Revolutionaries Need Apply to Lead California's $12 Billion Stem Cell/Gene Therapy Program

'Opportunity of a Lifetime:' It's in California and Involves Giving Away Billions for Stem Cell and Genetic Research

'Father' of California Stem Cell Agency Tussles with Giant Pension Fund over Millions in Real Estate Deal

Framing California's New Priorities for Billions in Gene Therapy and Stem Cell Research: A Look at the Key People

CIRM's 'Adventure with a Deadline:' How Billions will be Spent Pursuing Stem Cell and Gene Therapies

A Plea in a Deadly Family Affair: Lingering Fallout from California's Hold on Applications for Millions in Research Dollars

This is Not a Stem Cell Item

CIRM CEO Search: 100 Plus 'Applicants' Hoping to Lead the Quest for Revolutionary Treatments Backed by Billions from California

California's Multibillion-Dollar Stem Cell and Gene Therapy Agency Headed Towards New Directions

From Parkinson's to Stroke: A CIRM Report Card on Progress and More than $1 Billion in Taxpayer Spending

Does California Have a Plan to Sustain its Multibillion-Dollar Search for Revolutionary Stem Cell and Gene Therapies?

Cancer, Lupus, Parkinson's: All Targets of Latest $56 Million in Clinical Research Funding by California Stem Cell Agency

Winning Over Voters: Not Really a Traditional Stem Cell Challenge but Vital to California Stem Cell Agency

Bubble Babies and California Cures: Long-Awaited Good News for One Child and Not-So-Good News on More Funding

California Breaks Century Mark in Funding Clinical Trials for Stem Cell and Gene Therapies

California Places Hold on a "Tsumani" of Applications for Millions to Finance Clinical Stage Stem Cell and Gene Therapy Research

Scientists Urge "No" on CIRM Hold on Clinical Stage Research Applications, Tens of Millions of Dollars at Stake

Flooded with Clinical Applications, a Strained CIRM Readies to Place Five-Month Hold on the Proposals

Q&A on CIRM's Plans to Suspend Clinical Applications for Five Months

The CIRM CEO Search: New President by June 1, That's the Timetable

Once Terrific News for California Stem Cell Agency Turned Negative Today

Golden State is Great for Stem Cell and Gene Therapy Research, Says BIOCom California Chief Panetta.

Biden Fund-Raiser to be Hosted by the 'Father' of the $12 Billion California Stem Cell/Gene Research Agency

San Francisco Lawsuit Charges: A Missing Skull, Alleged Retaliation and CIRM Working Group Member

Human Embryo Models and California Regulation: More Info from CIRM Now Available

Tracking the CIRM: Profound Questions for California Stem Cell Financing, CIRM Performance Audit and More

Update on Klein-CalPERS Dispute: Klein Says Allegations 'Provably False'

$38 Million Dispute Between California State Retirement Fund and 'Father' of State Stem Cell Agency

Update on Research Misconduct Allegations: CIRM Removes Scientist Involved in its Application Review Process

California Stem Cell Agency Suspends Harvard Scientist from its Award Process following Allegations of Research Misconduct

California Stem Cell Agency Ratifies $1 Million Clinical Trial for One Person, Puts Hold on Future One-Person Trial Proposals

From Morocco to San Diego: One-Person Clinical Trials, Gene Therapies and CIRM

California Neuro Disease Research Update: A Search for Unique Opportunities and Bottlenecks to Break

This is Not a Stem Cell Item

A Sidetracked, $1 Million, One-Person Clinical Trial to Receive Fresh Hearing Next Week at California Stem Cell Agency

An 'n of 1' Conundrum: California's Gene Therapy Agency Wrestles with a Trial for an 'Extremely, Extremely' Rare Disorder

California's Stem Cell Agency Hides Top-Notch Equity and Inclusion Plans From the Public

Tracking the CIRM: 'Life Beyond 2023,' Closed Door DEI Session, $60 Million Building Program for Hinterland Community Centers

California's Stem Cell and Gene Therapy Agency Troubled by Morale Problems, Pay Inequality and More, Says Audit

An Advisory on an Errant Post

A Quicky Review of CIRM Finances; More Scrutiny of Stem Cell Agency Promised in February

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts